Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 24,144 | 20,499 | 21,594 | 22,023 | 23,625 |
| Cost of Goods | 12,431 | 6,994 | 7,060 | 6,233 | 4,972 |
| Gross Profit | 11,713 | 13,505 | 14,534 | 15,790 | 18,653 |
| Operating Expenses | 57,008 | 65,098 | 149,304 | 68,492 | 73,926 |
| Operating Income | -44,864 | -50,599 | -134,710 | -52,469 | -54,301 |
| Interest Expense | 5,910 | 6,152 | 6,405 | 7,201 | 6,953 |
| Other Income | 4,876 | 5,582 | 4,034 | 3,126 | 2,050 |
| Pre-tax Income | -45,898 | -51,169 | -137,081 | -56,544 | -59,204 |
| Income Tax | -61 | -47 | -63 | 3,144 | -155 |
| Net Income Continuous | -45,837 | -51,122 | -137,018 | -59,688 | -59,049 |
| Net Income | $-45,837 | $-51,122 | $-137,018 | $-59,688 | $-59,049 |
| EPS Basic Total Ops | -3.60 | -4.05 | -10.94 | -4.80 | -4.65 |
| EPS Basic Continuous Ops | -3.61 | -4.04 | -10.88 | -4.72 | -4.72 |
| EPS Diluted Total Ops | -3.60 | -4.05 | -10.94 | -4.80 | -4.65 |
| EPS Diluted Continuous Ops | -3.61 | -4.04 | -10.88 | -4.72 | -4.72 |
| EBITDA(a) | $-47,156 | $-53,454 | $-59,036 | $-48,915 | $-52,696 |